Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 6, 2009, Pages

  Krenning, Guido ^a   Dankers, Patricia Y W ^a,c   Drouven, Johannes W ^a   Waanders, Femke ^a   Franssen, Casper F M ^a,b   Van Luyn, Marja J A ^a   Harmsen, Martin C ^a   Popa, Eliane R ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Cardiovascular disease; CD14; CD34; Hemodialysis; Peritoneal dialysis

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; FIBRONECTIN;

ADULT; ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIALYSIS; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGENERATIVE MEDICINE; STEM CELL;

EID: 66449132290     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90755.2008     Document Type: Article

References (45)

1. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287: C572-C579, 2004. (Pubitemid 39095841)
2. Asahara T, Murohara T, Sullivan A, Silver M, vanderZee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
3. Bahlmann FH, de Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D. Erythropoietin regulates endothelial progenitor cells. Blood 103: 921-926, 2004. (Pubitemid 38129551)
4. Bahlmann FH, Degroot K, Duckert T, Niemczyk E, Bahlmann E, Boehm SM, Haller H, Fliser D. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64: 1648-1652, 2003. (Pubitemid 37323692)
5. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24: 1246-1252, 2004. (Pubitemid 38880016)
6. Coppolino G, Bolignano D, Campo S, Loddo S, Teti D, Buemi M. Circulating progenitor cells after cold pressor test in hypertensive and uremic patients. Hypertens Res 31: 717-724, 2008.
7. Dankers PYW, Harmsen MC, Brouwer LA, van Luyn MJA, Meijer EW. A modular and supramolecular approach to bioactive scaffolds for tissue engineering. Nat Mater 4: 568-574, 2005. (Pubitemid 40952755)
8. Dankers PYW, van Leeuwen ENM, van Gemert GML, Spiering AJH, Harmsen MC, Brouwer LA, Janssen HM, Bosman AW, van Luyn MJA, Meijer EW. Chemical and biological properties of supramolecular polymer systems based on oligocaprolactones. Biomaterials 27: 5490-5501, 2006. (Pubitemid 44176150)
9. de Groot K, Hermann Bahlmann F, Sowa J, Koenig J, Menne J, Haller H, Fliser D. Uremia causes endothelial progenitor cell deficiency. Kidney Int 66: 641-646, 2004. (Pubitemid 38982006)
10. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 82: 671-677, 2004. (Pubitemid 39468491)
11. Freedman MH, Cattran DC, Saunders EF. Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serum. Nephron 35: 15-19, 1983.
12. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346, 2003. (Pubitemid 36988041)
13. Hotta T, Maeda H, Suzuki I, Chung TG, Saito A. Selective inhibition of erythropoiesis by sera from patients with chronic renal failure. Proc Soc Exp Biol Med 186: 47-51, 1987. (Pubitemid 17143747)
14. Hur J, Yoon C, Kim H, Choi J, Kang H, Hwang K, Oh BH, Lee M, Park Y. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293, 2004. (Pubitemid 38197580)
15. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz M, Gilley D, Yoder M. Identification of a novel hierarchy of endothelial progenitor cells utilizing human peripheral and umbilical cord blood. Blood 104: 2752-2760, 2004. (Pubitemid 39434958)
16. Jacobson SH, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 22: 42-47, 2002. (Pubitemid 34264185)
17. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7: 1035-1040, 2001. (Pubitemid 32937384)
18. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 3: 221-225, 2002. (Pubitemid 37329397)
19. + monocytic cells into endothelial cells on degradable biomaterials. Biomaterials 28: 1470-1479, 2007.
20. Krenning G, Moonen JR, van Luyn MJ, Harmsen MC. Generating new blood flow: integrating developmental biology and tissue engineering. Trends Cardiovasc Med 18: 312-323, 2008.
21. + endothelial progenitor cells in vitro. J Cell Mol Med. In press.
22. Krenning G, van Luyn MJA, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 15: 180-189, 2009.
23. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der MJ. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 117: 224-230, 2008.
24. Mall J, Philipp AW, Rademacher A, Paulitschke M, Buttemeyer R. Re-endothelialization of punctured ePTFE graft: an in vitro study under pulsed perfusion conditions. Nephrol Dial Transplant 19: 61-67, 2004. (Pubitemid 38072616)
25. Moonen JRAJ, de Leeuw K, van Seijen X, Kallenberg C, van Luyn MJA, Bijl M, Harmsen MC. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 9: R84, 2007. (Pubitemid 47517251)
26. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002.
27. + progenitor cells modulate host angiogenesis and inflammation in vivo. J Mol Cell Cardiol 41: 86-96, 2006.
28. Rodriguez-Ayala E, Yao Q, Holmen C, Lindholm B, Sumitran-Holgersson S, Stenvinkel P. Imbalance between detached circulating endothelial cells and endothelial progenitor cells in chronic kidney disease. Blood Purif 24: 196-202, 2006. (Pubitemid 43259174)
29. (low) cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97: 314-322, 2005.
30. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003. (Pubitemid 37337595)
31. Shepherd J, Kastelein JJP, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) Study. Clin J Am Soc Nephrol 2: 1131-1139, 2007.
32. Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D, Treating to New Targets Investigators. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: The Treating to New Targets (TNT) Study. Diabetes Care 29: 1220-1226, 2006. (Pubitemid 44125913)
33. Shepherd J, Kastelein JJP, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) Study. J Am Coll Cardiol 51: 1448-1454, 2008.
34. Shishehbor MH, Oliveira LPJ, Lauer MS, Sprecher DL, Wolski K, Cho L, Hoogwerf BJ, Hazen SL. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. Am J Cardiol 101: 1741-1746, 2008.
35. Stenvinkel P, Ekstrom TJ. Epigenetics and the uremic phenotype: a matter of balance. Contrib Nephrol 161: 55-62, 2008.
36. Stenvinkel P, Ekstrom TJ. Does the uremic milieu affect the epigenotype? J Ren Nutr 19: 82-85, 2009.
37. Stinghen AE, Goncalves SM, Martines EG, Nakao LS, Riella MC, Aita CA, Pecoits-Filho R. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract 111: c117-c126, 2009.
38. Sturiale A, Coppolino G, Loddo S, Criseo M, Campo S, Crasci E, Bolignano D, Nostro L, Teti D, Buemi M. Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif 25: 242-251, 2007. (Pubitemid 47074637)
39. + hematopoietic cells. J Leukoc Biol 75: 671-679, 2004.
40. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110: 1209-1212, 2004.
41. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher A, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001. (Pubitemid 32578123)
42. Walter D, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024, 2002. (Pubitemid 34693836)
43. Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 19: 135-140, 2008.
44. Werner N, Nickenig G. Endothelial progenitor cells in health and atherosclerotic disease. Ann Med 39: 82-90, 2007. (Pubitemid 46598174)
45. Westerweel PE, Hoefer IE, Blankestijn PJ, de Bree P, Groeneveld D, van Oostrom O, Braam B, Koomans HA, Verhaar MC. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol 292: F1132-F1140, 2007. (Pubitemid 46572432)